Related Experiment Video
Updated: Jun 27, 2026
08:40
Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
Pathogenic mutations shift the equilibria of alpha-synuclein single molecules towards structured conformers
Marco Brucale1, Massimo Sandal, Selena Di Maio
1Department of Biochemistry, University of Bologna, via Irnerio 48, Bologna, Italy.
Chembiochem : a European Journal of Chemical Biology
|December 11, 2008
Summary
Parkinson's disease mutations in alpha-synuclein (alpha-Syn) protein increase its tendency to adopt a compact, beta-sheet-rich structure. This conformational shift in alpha-Syn mutants promotes protein aggregation, offering insights into early-onset Parkinson's disease.
Area of Science:
- Neuroscience
- Biochemistry
- Structural Biology
Background:
- Alpha-synuclein (alpha-Syn) is a brain protein implicated in Parkinson's disease (PD) pathogenesis.
- Mutations in alpha-Syn are linked to early-onset PD.
- Previous studies suggest alpha-Syn conformational changes are associated with PD.
Purpose of the Study:
- To characterize the conformational heterogeneity of pathological alpha-synuclein mutants (A30P, A53T, E46K) using single-molecule force spectroscopy (SMFS).
- To compare the conformational behavior of alpha-Syn mutants with wild-type (WT) alpha-Syn.
- To investigate how specific mutations influence alpha-Syn conformation and aggregation propensity.
Main Methods:
- Single-molecule force spectroscopy (SMFS) was employed to probe the conformational landscape of individual alpha-Syn molecules.
- The methodology allowed for the detection of subtle conformational differences not apparent in bulk measurements.
- Conformational equilibrium and stability of mechanically weak interactions (MWI) were analyzed for WT and mutant alpha-Syn.
Main Results:
- All tested alpha-Syn mutants (A30P, A53T, E46K) exhibit a significantly higher propensity than WT alpha-Syn to adopt compact, beta-sheet-compatible conformations in their monomeric state.
- Mutants A30P and A53T displayed similar conformational equilibria, distinct from E46K.
- Mutants showed greater variety in MWI-stabilized conformations, with A30P exhibiting stronger MWI, suggesting more structured conformations.
Conclusions:
- The study reveals distinct conformational behaviors between alpha-Syn mutants and WT, driven by specific mutations.
- The increased propensity of mutants to adopt structured, compact conformations explains their heightened aggregation tendency.
- These findings provide molecular insights into the mechanisms underlying early-onset Parkinson's disease linked to alpha-Syn mutations.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:39Mutations
Overview
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
01:30Point and Frameshift Mutations
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...